Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.370
-0.020 (-1.44%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Vivani Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 9.43 | 8.93 | 10 | 5.37 | 2.32 | |
| Research & Development | 18.13 | 15.75 | 16.97 | 14.17 | 11 | |
| Operating Expenses | 27.56 | 24.68 | 26.97 | 19.54 | 13.32 | |
| Operating Income | -27.56 | -24.68 | -26.97 | -19.54 | -13.32 | |
| Other Non Operating Income (Expenses) | 0.95 | 1.19 | 1.31 | 0.48 | 0.55 | |
| EBT Excluding Unusual Items | -26.61 | -23.49 | -25.65 | -19.07 | -12.77 | |
| Legal Settlements | - | - | - | -1.7 | - | |
| Other Unusual Items | - | - | - | 6.88 | - | |
| Pretax Income | -26.61 | -23.49 | -25.65 | -13.89 | -12.77 | |
| Earnings From Continuing Operations | -26.61 | -23.49 | -25.65 | -13.89 | -12.77 | |
| Net Income | -26.61 | -23.49 | -25.65 | -13.89 | -12.77 | |
| Net Income to Common | -26.61 | -23.49 | -25.65 | -13.89 | -12.77 | |
| Shares Outstanding (Basic) | 62 | 55 | 51 | 38 | 33 | |
| Shares Outstanding (Diluted) | 62 | 55 | 51 | 38 | 33 | |
| Shares Change (YoY) | 13.47% | 8.12% | 32.98% | 15.56% | 234.38% | |
| EPS (Basic) | -0.43 | -0.43 | -0.50 | -0.36 | -0.39 | |
| EPS (Diluted) | -0.43 | -0.43 | -0.50 | -0.36 | -0.39 | |
| Free Cash Flow | -25.49 | -21.34 | -24.59 | -19.13 | -11.52 | |
| Free Cash Flow Per Share | -0.41 | -0.39 | -0.48 | -0.50 | -0.35 | |
| EBITDA | -27.13 | -24.28 | -26.61 | -19.16 | -12.98 | |
| D&A For EBITDA | 0.42 | 0.4 | 0.36 | 0.38 | 0.35 | |
| EBIT | -27.56 | -24.68 | -26.97 | -19.54 | -13.32 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.